Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Luis Gutierrez, Mara Aspinall, Greg Lucier, Valerie Palmieri

Premium

Theranostics Health has appointed Luis Gutierrez president and CEO. Former CEO Glenn Hoke will remain with the company as executive VP and COO.

Gutierrez was previously executive VP and COO of Aptiv Solutions. Before that he was president of Covance's commercialization services division. He has also held management roles at Merck and MedAssurant.


Safeguard Scientifics has appointed Mara Aspinall to its board of directors. Aspinall formerly served as president and CEO of Ventana Medical Systems and global head of Roche Tissue Diagnostics. Prior to that she had founded and served as CEO of On-Q-ity, and she also previously was president of Genzyme Genetics and president of Genzyme Pharmaceuticals.


Former Life Technologies CEO and chairman Greg Lucier has joined the board of directors at Invuity, a medical device company based in San Francisco. Prior to Life Tech, Lucier held senior management positions at General Electric, most recently CEO and president of Medical Systems Information Technologies for GE Healthcare. He holds an MBA from Harvard Business School and has a BS in industrial engineering from Pennsylvania State University.


Vermillion has appointed Valerie Palmieri to the newly created position of COO.

Previously, Palmieri was president of Momentum Consulting, through which she has served as a strategic advisor to Vermillion for the past six months, helping the company launch Aspira Labs, its CLIA certified facility. Prior to that she was CEO of two healthcare start-ups, as well as national VP of anatomic pathology operations at LabCorp/Dianon.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.